Literature DB >> 35122036

Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis.

Hin Ching Lo1,2,3, Zhan Xu1,2,4, Ik Sun Kim1,2,3, Bradley Pingel1,2,5, Sergio Aguirre1,2,3, Srikanth Kodali3, Jun Liu1,2,4, Weijie Zhang1,2,4, Aaron M Muscarella1,2,3, Sarah M Hein6,7, Alexander S Krupnick8, Joel R Neilson2,3,9, Silke Paust10, Jeffrey M Rosen2,4, Hai Wang1,2,4, Xiang H-F Zhang11,12,13,14.   

Abstract

Polyclonal metastases frequently arise from clusters of circulating tumor cells (CTCs). CTC clusters metastasize better than single CTCs, but the underlying molecular mechanisms are poorly understood. Here, we show that polyclonal metastatic seeds exhibit higher resistance to natural killer (NK) cell killing. Using breast cancer models, we observed higher proportions of polyclonal lung metastasis in immunocompetent mice compared with mice lacking NK cells. Depleting NK cells selectively increased monoclonal but not polyclonal metastases, suggesting that CTC clusters are less sensitive to NK-mediated suppression. Transcriptional analyses revealed that clusters have elevated expression of cell-cell adhesion and epithelial genes, which is associated with decreased expression of NK cell activating ligands. Furthermore, perturbing tumor cell epithelial status altered NK ligand expression and sensitivity to NK-mediated killing. Collectively, our findings show that NK cells can determine the fate of CTCs of different epithelial and mesenchymal states, and impact metastatic clonal evolution by favoring polyclonal seeding.
© 2020. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2020        PMID: 35122036     DOI: 10.1038/s43018-020-0068-9

Source DB:  PubMed          Journal:  Nat Cancer        ISSN: 2662-1347


  49 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.

Authors:  Nicole M Aiello; Ravikanth Maddipati; Robert J Norgard; David Balli; Jinyang Li; Salina Yuan; Taiji Yamazoe; Taylor Black; Amine Sahmoud; Emma E Furth; Dafna Bar-Sagi; Ben Z Stanger
Journal:  Dev Cell       Date:  2018-06-18       Impact factor: 12.270

3.  Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer.

Authors:  Maximilian Reichert; Basil Bakir; Leticia Moreira; Jason R Pitarresi; Karin Feldmann; Lauren Simon; Kensuke Suzuki; Ravikanth Maddipati; Andrew D Rhim; Anna M Schlitter; Mark Kriegsmann; Wilko Weichert; Matthias Wirth; Kathleen Schuck; Günter Schneider; Dieter Saur; Albert B Reynolds; Andres J Klein-Szanto; Burcin Pehlivanoglu; Bahar Memis; N Volkan Adsay; Anil K Rustgi
Journal:  Dev Cell       Date:  2018-06-18       Impact factor: 12.270

Review 4.  Metastatic colonization by circulating tumour cells.

Authors:  Joan Massagué; Anna C Obenauf
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

5.  Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.

Authors:  Marni B Siegel; Xiaping He; Katherine A Hoadley; Alan Hoyle; Julia B Pearce; Amy L Garrett; Sunil Kumar; Vincent J Moylan; Claudia M Brady; Amanda Ed Van Swearingen; David Marron; Gaorav P Gupta; Leigh B Thorne; Niamh Kieran; Chad Livasy; Elaine R Mardis; Joel S Parker; Mengjie Chen; Carey K Anders; Lisa A Carey; Charles M Perou
Journal:  J Clin Invest       Date:  2018-02-26       Impact factor: 14.808

6.  Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.

Authors:  Kevin J Cheung; Veena Padmanaban; Vanesa Silvestri; Koen Schipper; Joshua D Cohen; Amanda N Fairchild; Michael A Gorin; James E Verdone; Kenneth J Pienta; Joel S Bader; Andrew J Ewald
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

7.  The evolutionary history of lethal metastatic prostate cancer.

Authors:  Christopher Foster; Douglas Easton; Ultan McDermott; David C Wedge; G Steven Bova; Gunes Gundem; Peter Van Loo; Barbara Kremeyer; Ludmil B Alexandrov; Jose M C Tubio; Elli Papaemmanuil; Daniel S Brewer; Heini M L Kallio; Gunilla Högnäs; Matti Annala; Kati Kivinummi; Victoria Goody; Calli Latimer; Sarah O'Meara; Kevin J Dawson; William Isaacs; Michael R Emmert-Buck; Matti Nykter; Zsofia Kote-Jarai; Hayley C Whitaker; David E Neal; Colin S Cooper; Rosalind A Eeles; Tapio Visakorpi; Peter J Campbell
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

8.  Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.

Authors:  Lukas Klameth; Barbara Rath; Maximilian Hochmaier; Doris Moser; Marlene Redl; Felicitas Mungenast; Katharina Gelles; Ernst Ulsperger; Robert Zeillinger; Gerhard Hamilton
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

9.  Detection of circulating tumour cell clusters in human glioblastoma.

Authors:  Ilona Krol; Francesc Castro-Giner; Martina Maurer; Sofia Gkountela; Barbara Maria Szczerba; Ramona Scherrer; Niamh Coleman; Suzanne Carreira; Felix Bachmann; Stephanie Anderson; Marc Engelhardt; Heidi Lane; Thomas Ronald Jeffry Evans; Ruth Plummer; Rebecca Kristeleit; Juanita Lopez; Nicola Aceto
Journal:  Br J Cancer       Date:  2018-08-01       Impact factor: 9.075

Review 10.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

View more
  11 in total

1.  Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres.

Authors:  Barbara Breznik; Meng-Wei Ko; Christopher Tse; Po-Chun Chen; Emanuela Senjor; Bernarda Majc; Anamarija Habič; Nicolas Angelillis; Metka Novak; Vera Župunski; Jernej Mlakar; David Nathanson; Anahid Jewett
Journal:  Commun Biol       Date:  2022-05-10

2.  CXCR6+ and NKG2C+ Natural Killer Cells Are Distinct With Unique Phenotypic and Functional Attributes Following Bone Marrow Transplantation.

Authors:  Kevin Aviles-Padilla; Laura S Angelo; Dwight Fan; Silke Paust
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 3.  Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.

Authors:  Nicholas A Maskalenko; Dmitry Zhigarev; Kerry S Campbell
Journal:  Nat Rev Drug Discov       Date:  2022-03-21       Impact factor: 112.288

Review 4.  Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.

Authors:  Riley D Z Mullins; Ananya Pal; Thomas F Barrett; Molly E Heft Neal; Sidharth V Puram
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

5.  Cellular plasticity in bone metastasis.

Authors:  Cao Fang; Yibin Kang
Journal:  Bone       Date:  2020-10-15       Impact factor: 4.398

Review 6.  An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets.

Authors:  Eunice Dotse; King H Lim; Meijun Wang; Kevin Julio Wijanarko; Kwan T Chow
Journal:  Life (Basel)       Date:  2022-02-21

7.  The metabolism of cells regulates their sensitivity to NK cells depending on p53 status.

Authors:  Sana Belkahla; Joaquin Marco Brualla; Alexis Fayd'herbe de Maudave; Paolo Falvo; Nerea Allende-Vega; Michael Constantinides; Abrar Ul Haq Khan; Lois Coenon; Catherine Alexia; Giulia Mitola; Paul Massa; Stefania Orecchioni; Francesco Bertolini; Wissem Mnif; Javier Hernandez; Alberto Anel; Martin Villalba
Journal:  Sci Rep       Date:  2022-02-25       Impact factor: 4.996

Review 8.  (Im)maturity in Tumor Ecosystem.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 9.  The changing role of natural killer cells in cancer metastasis.

Authors:  Isaac S Chan; Andrew J Ewald
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

Review 10.  Mechanisms of breast cancer metastasis.

Authors:  S David Nathanson; Michael Detmar; Timothy P Padera; Lucy R Yates; Danny R Welch; Thomas C Beadnell; Adam D Scheid; Emma D Wrenn; Kevin Cheung
Journal:  Clin Exp Metastasis       Date:  2021-05-05       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.